A new plasmidic cefotaximase from patients infected with Salmonella typhimurium.

作者: A. Bauernfeind , M. Holley , R. Jungwirth , P. Mangold , T. Röhnisch

DOI: 10.1007/BF01704610

关键词: VirologyAmpicillinBiologyCeftriaxoneCefotaximeTazobactamSulbactamGentamicinMicrobiologyClavulanic acidCeftazidime

摘要: Salmonella typhimurium strains resistant to most β-lactams, co-trimoxazole, tobramycin and gentamicin were isolated from patients in two hospitals Buenos Aires, Argentina, beginning August 1990. The suffering meningitis, septicaemia or enteritis. Therapy including ampicillin, ceftriaxone failed. produced a plasmidic (pMVP-4) extended broad-spectrum β-lactamase which is more active against cefotaxime than ceftazidime (Vmax for 350 times higher ceftazidime). This cefotaximase demonstrates similarity the previously described CTX-ase-M-1 fromEscherichia coli, but it distinctly different by its isoelectric point (7.9 CTX-ase-M-2 comparison with 8.9 CTX-ase-M-1) as well lower susceptibility inhibitors sulbactam, clavulanic acid, tazobactam BRL 42715. Thus, byS. Argentina appears represent new member (CTX-ase-M-2) of novel group β-lactamases designated cefotaximases.

参考文章(11)
A. Bauernfeind, S. Schweighart, H. Grimm, A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection. ,vol. 18, pp. 294- 298 ,(1990) , 10.1007/BF01647010
Michel Barthélémy, Jean Péduzzi, Hervé Bernard, Cyril Tancrède, Roger Labia, Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum β-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca Biochimica et Biophysica Acta. ,vol. 1122, pp. 15- 22 ,(1992) , 10.1016/0167-4838(92)90121-S
L Gutmann, B Ferre, F W Goldstein, N Rizk, E Pinto-Schuster, J F Acar, E Collatz, SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrobial Agents and Chemotherapy. ,vol. 33, pp. 951- 956 ,(1989) , 10.1128/AAC.33.6.951
A. Bure, P. Legrand, G. Arlet, V. Jarlier, G. Paul, A. Philippon, Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 7, pp. 780- 782 ,(1988) , 10.1007/BF01975048
M. MATTHEW, A. M. HARRIS, M. J. MARSHALL, G. W. ROSS, The use of analytical isoelectric focusing for detection and identification of beta-lactamases. Microbiology. ,vol. 88, pp. 169- 178 ,(1975) , 10.1099/00221287-88-1-169
H. BERNARD, C. TANCREDE, V. LIVRELLI, A. MORAND, M. BARTHELEMY, R. LABIA, A novel plasmid-mediated extended-spectrum beta-lactamase not derived from TEM- or SHV-type enzymes. Journal of Antimicrobial Chemotherapy. ,vol. 29, pp. 590- 592 ,(1992) , 10.1093/JAC/29.5.590
Hans Lineweaver, Dean Burk, The Determination of Enzyme Dissociation Constants Journal of the American Chemical Society. ,vol. 56, pp. 658- 666 ,(1934) , 10.1021/JA01318A036
G A Jacoby, A A Medeiros, More extended-spectrum beta-lactamases. Antimicrobial Agents and Chemotherapy. ,vol. 35, pp. 1697- 1704 ,(1991) , 10.1128/AAC.35.9.1697
A Philippon, R Labia, G Jacoby, Extended-spectrum beta-lactamases. Antimicrobial Agents and Chemotherapy. ,vol. 33, pp. 1131- 1136 ,(1989) , 10.1128/AAC.33.8.1131
D. Sirot, J. Sirot, R. Labia, A. Morand, P. Courvalin, A. Darfeuille-Michaud, R. Perroux, R. Cluzel, Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamase Journal of Antimicrobial Chemotherapy. ,vol. 20, pp. 323- 334 ,(1987) , 10.1093/JAC/20.3.323